
Cannabis Community, Investors React to DEA Decision To Reschedule
Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many activists say the move does not go far enough.

Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many activists say the move does not go far enough.

The DEA under the Biden administration finally proposed the process of moving cannabis to Schedule III.

The DEA is challenging an attempt by a Seattle physician to give psilocybin to terminally ill patients struggling with anxiety.

Three Republican senators are calling on the DEA to reject a Biden administration proposal to reschedule marijuana under federal drug laws.

Cannabis advocates hailed the DEA’s decision to reclassify marijuana under federal drugs laws, although many activists say the move does not go far enough.

The DEA under the Biden administration finally proposed the process of moving cannabis to Schedule III.

The DEA is challenging an attempt by a Seattle physician to give psilocybin to terminally ill patients struggling with anxiety.

Three Republican senators are calling on the DEA to reject a Biden administration proposal to reschedule marijuana under federal drug laws.
Get notified of our the latest cannabis news, exclusive brand deals, events updates and more!
